Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer

Su Jung Kim; Dong Wan Kim; Tae Min Kim; Se Hoon Lee; Dae Seog Heo; Yung Jue Bang

doi:10.1200/JCO.2011.39.9766

Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer

Su Jung Kim
, Dong Wan Kim
, Tae Min Kim
, Se Hoon Lee
, Dae Seog Heo
, Yung Jue Bang

Seoul National University

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Original language	English
Pages (from-to)	e147-e150
Journal	Journal of Clinical Oncology
Volume	30
Issue number	16
DOIs	https://doi.org/10.1200/JCO.2011.39.9766
State	Published - 1 Jun 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1200/JCO.2011.39.9766

Cite this

@article{b5c662efa5b94df19956619f6c9e18c8,

title = "Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer",

author = "Kim, \{Su Jung\} and Kim, \{Dong Wan\} and Kim, \{Tae Min\} and Lee, \{Se Hoon\} and Heo, \{Dae Seog\} and Bang, \{Yung Jue\}",

year = "2012",

month = jun,

day = "1",

doi = "10.1200/JCO.2011.39.9766",

language = "English",

volume = "30",

pages = "e147--e150",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "16",

}

TY - JOUR

T1 - Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer

AU - Kim, Su Jung

AU - Kim, Dong Wan

AU - Kim, Tae Min

AU - Lee, Se Hoon

AU - Heo, Dae Seog

AU - Bang, Yung Jue

PY - 2012/6/1

Y1 - 2012/6/1

UR - https://www.scopus.com/pages/publications/84863944214

U2 - 10.1200/JCO.2011.39.9766

DO - 10.1200/JCO.2011.39.9766

M3 - Article

C2 - 22508824

AN - SCOPUS:84863944214

SN - 0732-183X

VL - 30

SP - e147-e150

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

ER -

Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer

UN SDGs

Access to Document

Other files and links

Cite this